BG105018A - Poly(adp-ribose)polymerase gene - Google Patents

Poly(adp-ribose)polymerase gene

Info

Publication number
BG105018A
BG105018A BG105018A BG10501800A BG105018A BG 105018 A BG105018 A BG 105018A BG 105018 A BG105018 A BG 105018A BG 10501800 A BG10501800 A BG 10501800A BG 105018 A BG105018 A BG 105018A
Authority
BG
Bulgaria
Prior art keywords
adp
ribose
poly
parp
polymerase
Prior art date
Application number
BG105018A
Other languages
Bulgarian (bg)
English (en)
Inventor
Michael Kock
Thomas Hoeger
Burkhard Kroeger
Bernd Otterbach
Wilfried Lubisch
Hans-Georg Lemaire
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of BG105018A publication Critical patent/BG105018A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1077Pentosyltransferases (2.4.2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/02Pentosyltransferases (2.4.2)
    • C12Y204/0203NAD+ ADP-ribosyltransferase (2.4.2.30), i.e. tankyrase or poly(ADP-ribose) polymerase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91091Glycosyltransferases (2.4)
    • G01N2333/91142Pentosyltransferases (2.4.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BG105018A 1998-06-05 2000-12-04 Poly(adp-ribose)polymerase gene BG105018A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19825213 1998-06-05
DE19908837 1999-03-01
PCT/EP1999/003889 WO1999064572A2 (de) 1998-06-05 1999-06-04 Poly(adp-ribose) polymerase-gene

Publications (1)

Publication Number Publication Date
BG105018A true BG105018A (en) 2001-12-31

Family

ID=26046644

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105018A BG105018A (en) 1998-06-05 2000-12-04 Poly(adp-ribose)polymerase gene

Country Status (24)

Country Link
US (3) US7754459B1 (es)
EP (1) EP1082416B1 (es)
JP (1) JP2002517231A (es)
KR (1) KR20010052582A (es)
CN (1) CN1304446A (es)
AR (1) AR020326A1 (es)
AT (1) ATE358175T1 (es)
AU (1) AU4605999A (es)
BG (1) BG105018A (es)
BR (1) BR9910967A (es)
CA (1) CA2330206C (es)
CO (1) CO5070700A1 (es)
DE (1) DE59914280D1 (es)
ES (1) ES2285842T3 (es)
HK (1) HK1038591A1 (es)
HR (1) HRP20010013A2 (es)
HU (1) HUP0103190A2 (es)
ID (1) ID27819A (es)
IL (1) IL139750A0 (es)
NO (1) NO20006153L (es)
PL (1) PL345334A1 (es)
SK (1) SK17892000A3 (es)
TR (1) TR200003624T2 (es)
WO (1) WO1999064572A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921567A1 (de) 1999-05-11 2000-11-16 Basf Ag Verwendung von Phthalazine-Derivaten
US6599727B1 (en) 1999-06-16 2003-07-29 Icos Corporation Human poly (ADP-ribose) polymerase 2 materials and methods
DE50112961D1 (de) 2000-02-01 2007-10-18 Abbott Gmbh & Co Kg Heterozyklische verbindungen und deren anwendung als parp-inhibitoren
SG164368A1 (en) 2005-07-18 2010-09-29 Bipar Sciences Inc Treatment of cancer
WO2008030891A2 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
CA2662517A1 (en) 2006-09-05 2008-03-13 Jerome Moore Treatment of cancer
US7732491B2 (en) 2007-11-12 2010-06-08 Bipar Sciences, Inc. Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
GB201102857D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
GB201102865D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
CA2825365A1 (en) 2011-02-18 2012-08-23 Dupont Nutrition Biosciences Aps Feed additive composition
GB201213801D0 (en) 2012-08-03 2012-09-12 Dupont Nutrition Biosci Aps Feed additive composition
DK2890780T3 (da) 2012-08-29 2020-09-21 Sangamo Therapeutics Inc Fremgangsmåder og sammensætninger til behandling af en genetisk tilstand

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162508A (en) 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
FR2707011A1 (en) 1993-06-25 1994-12-30 Pasteur Sanofi Diagnostics Immunological process for the detection and assay of antibodies directed against poly(ADP-ribose) polymerase, application to diagnosis, kit for its implementation
DE4444949C1 (de) 1994-12-16 1996-11-21 Deutsches Krebsforsch Vektoren und Viren zur Gentherapie

Also Published As

Publication number Publication date
TR200003624T2 (tr) 2001-06-21
NO20006153D0 (no) 2000-12-04
AU4605999A (en) 1999-12-30
HRP20010013A2 (en) 2001-12-31
US20110107444A1 (en) 2011-05-05
CA2330206C (en) 2010-04-13
WO1999064572A2 (de) 1999-12-16
IL139750A0 (en) 2002-02-10
US9051553B2 (en) 2015-06-09
ES2285842T3 (es) 2007-11-16
CO5070700A1 (es) 2001-08-28
BR9910967A (pt) 2001-02-13
JP2002517231A (ja) 2002-06-18
US20160010067A1 (en) 2016-01-14
DE59914280D1 (en) 2007-05-10
HUP0103190A2 (hu) 2001-12-28
KR20010052582A (ko) 2001-06-25
EP1082416B1 (de) 2007-03-28
PL345334A1 (en) 2001-12-17
ATE358175T1 (de) 2007-04-15
AR020326A1 (es) 2002-05-08
NO20006153L (no) 2001-02-02
WO1999064572A3 (de) 2000-06-08
CN1304446A (zh) 2001-07-18
EP1082416A2 (de) 2001-03-14
HK1038591A1 (zh) 2002-03-22
US7754459B1 (en) 2010-07-13
CA2330206A1 (en) 1999-12-16
ID27819A (id) 2001-04-26
SK17892000A3 (sk) 2001-09-11

Similar Documents

Publication Publication Date Title
BG105018A (en) Poly(adp-ribose)polymerase gene
DE69836885D1 (de) Nachweis von Nukleinsäuren durch Fluoreszenz quenching
FR2703693B1 (fr) Procédé rapide de détermination d'une séquence d'ADN et application au séquençage et au diagnostic.
WO2003052110A3 (en) Nucleic acid nematicides
WO2001094617A3 (en) Protein fragment complementation assay based on beta-lactamase
DE69838724D1 (de) Polymerase-verbessernder faktor (pef)-enthaltende extrakte, pef proteinkomplexe, isoliertes pef protein und verfahren zur reinigung und identifizierung
DE60039986D1 (de) Nukleinsäureliganden von tenascin-c
ATE174065T1 (de) Simultane sequenzierung von nukleinsäuren
ATE304052T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
CA2170515A1 (en) Nucleotide sequences for novel protein tyrosine phosphatases
ES8500452A1 (es) Procedimiento de inmuno-analisis para determinar una iodotironina en un fluido biologico.
PT641215E (pt) Analogos de trombomodulina resistentes a proteases
ES2196010T3 (es) Spbfamilia ptp-d de proteinas tirosina fosfatasas.
DE69739346D1 (de) Gereinigtes sr-p70 protein
MX9503070A (es) Sistema de expresion que utiliza proteinas de fusion autolisables y un polipeptido de reduccion novedoso.
DE69836485D1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
DE69613685D1 (de) D-aminosäure-oxidase kodierendes dns-fragment
Rodgers et al. Activation of coagulation factor V by calcium-dependent proteinase
DK0890650T3 (da) Oligonykleotid egnet til påvisning af mælkesyrebakterier
WO2002062964A3 (en) Ap1 amine oxidase variants
ES2178203T3 (es) Metodos y reactivos para modular la apoptosis.
ATE312113T1 (de) Hemmung der denaturierung von nukleinsäure- duplexen
ATE301189T1 (de) Neues verfahren zum nachweis von cryptosporidium
FI973762A0 (fi) Ny gen
EP0214548A3 (en) Dna sequences, recombinant dna molecules and process for the preparation of the enzyme mutarotase of acinetobacter calcoaceticus